Published in Biochem Pharmacol on June 01, 1983
Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth. Br J Cancer (1989) 0.90
Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation. Br J Cancer (1988) 0.80
The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding. Br J Cancer (1992) 0.78
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
Impact of cane use on pain, function, general health and energy expenditure during gait in patients with knee osteoarthritis: a randomised controlled trial. Ann Rheum Dis (2011) 2.12
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest (1985) 1.97
HIV-I Tat: a polypeptide for all seasons. Immunol Today (1998) 1.92
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest (1982) 1.90
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol (2001) 1.88
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev (1997) 1.77
Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J Immunol (1997) 1.63
Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc Soc Exp Biol Med (1981) 1.51
The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur J Immunol (1997) 1.50
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer (2000) 1.50
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology (2004) 1.49
Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol (1987) 1.49
Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci U S A (1987) 1.47
Dermatomyositis associated with testicular germ cell cancer. J Urol (2000) 1.47
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost (2003) 1.42
Thrombin infusion in endotoxin-treated rabbits reduces the plasma levels of plasminogen activator inhibitor: evidence for a protein-C-mediated mechanism. Blood (1989) 1.42
Cancer cell procoagulant activity: evaluation by an amidolytic assay. Thromb Res (1980) 1.41
Early stratification of patients with chest pain and suspected acute coronary syndrome in the Emergency Department. Minerva Med (2010) 1.41
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation. Eur J Immunol (1986) 1.33
Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33
CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. Blood (2001) 1.31
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol (2001) 1.25
CD3+ WT31- peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer. Eur J Immunol (1987) 1.23
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology (2004) 1.23
Control of interleukin-18 secretion by dendritic cells: role of calcium influxes. FEBS Lett (2000) 1.22
Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol (2001) 1.21
Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation. J Exp Med (1987) 1.19
Pathogenesis of thrombosis in patients with malignancy. Int J Hematol (2001) 1.18
Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology (1983) 1.15
Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis (2009) 1.15
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med (1991) 1.15
Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res (1977) 1.14
Platelet hyperaggregability and the nephrotic syndrome. Thromb Res (1979) 1.12
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis (2001) 1.09
Evidence that cells from experimental tumours can activate coagulation factor X. Br J Cancer (1979) 1.07
Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost (2001) 1.07
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity. Thromb Res (1979) 1.05
Malignancy and haemostasis. Br J Haematol (1980) 1.04
Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J (Clin Res Ed) (1985) 1.04
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol (1984) 1.02
Bone changes in end-stage oxalosis. AJR Am J Roentgenol (1981) 1.02
The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy (2006) 1.01
Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int (1989) 1.00
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol (1970) 1.00
Tissue factor in health and disease. Thromb Haemost (1997) 0.99
Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific T cells. J Leukoc Biol (1999) 0.99
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest (1998) 0.99
HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. J Immunol (1998) 0.99
Typical breakfast food consumption and risk factors for cardiovascular disease in a large sample of Italian adults. Nutr Metab Cardiovasc Dis (2010) 0.98
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis (2001) 0.98
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. Int Immunol (1996) 0.98
Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost (2007) 0.98
Signal transducing mechanisms involved in human T cell activation via surface T44 molecules. Comparison with signals transduced via the T cell receptor complex. Eur J Immunol (1986) 0.98
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Thromb Haemost (1996) 0.97
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. J Viral Hepat (2012) 0.97
Specific binding of human fibrinogen to cultured human fibroblasts. Evidence for the involvement of the E domain. Eur J Biochem (1984) 0.96
Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor-VIII-related antigen. Br J Haematol (1974) 0.95
A new procoagulant in acute leukemia. Blood (1988) 0.95
Aggregation of human platelets by bovine or human factor VIII: role of carbohydrate side chains. Nature (1973) 0.95
Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis. Thromb Res (1978) 0.95
Characterization of the immunostimulants levamisole and tetramisole. Eur J Cancer (1975) 0.94
Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis (2011) 0.94
The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells. AIDS (1997) 0.94
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res (1997) 0.94
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arterioscler Thromb (1993) 0.93
Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J Biol Chem (2001) 0.93
Interaction of platelets with bacterial endotoxins. Agents Actions (1983) 0.92
Defective fibrinolytic and prostacyclin-like activity in human atheromatous plaques. Thromb Haemost (1978) 0.92
Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res (1986) 0.92